等待开盘 05-19 09:30:00 美东时间
-1.000
-5.96%
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从11美元升至12美元;Ladenburg Thalmann:维持Usio"买入"评级,目标价从5.75美元升至6.25美元
05-18 11:48
B. Riley Securities analyst Fedor Shabalin maintains Strive (NASDAQ:ASST) with a Buy and raises the price target from $19 to $20.
05-16 00:57
Strive (NASDAQ:ASST) reported quarterly losses of $(5.19) per share which missed the analyst consensus estimate of $(2.56) by 102.73 percent. This is a 220.37 percent decrease over losses of $(1.62) per share from the
05-14 21:04
华盛资讯5月14日讯,Strive公布2026财年Q1业绩,公司Q1营收0.03亿美元,同比增长94.0%,归母净利润亏损2.79亿美元,同比亏损扩大7351.6%。
05-14 20:05
华盛资讯5月14日讯,Strive公布2026财年Q1业绩,公司Q1营收0.03亿美元,同比增长94.0%,归母净利润亏损2.79亿美元,同比亏损扩大7351.6%。
05-14 20:02
Strive Q1 FY26 net loss widens to $265.91 million; revenue rises 94% to $2.76 million Strive posted a net loss of $265.91 million for Q1 ended March 31, 2026, swinging from a loss of $3.75 million a year earlier. Operating loss widened to $313.15 million from $4.07 million, driven by a net unrealize
05-14 19:49
诺基亚剥离非核心资产,看涨期权占比逾9成,一CALL单大涨近300%;美光大涨6%股价再创新高,获一CALL单押注看多至1000美元>>
05-12 19:49
Insulet (NASDAQ:PODD) reported first-quarter financial results on Wednesday. Th...
05-06 21:07
Strive Inc ( ($ASST) ) has shared an update. On May 4, 2026, Strive, Inc. repor...
05-04 20:43